PYREXIA is the #8 most commonly reported adverse reaction for PEGINTERFERON ALFA 2A, manufactured by pharmaand GmbH. There are 3,471 FDA adverse event reports linking PEGINTERFERON ALFA 2A to PYREXIA. This represents approximately 2.5% of all 141,362 adverse event reports for this drug.
PEGINTERFERON ALFA 2A has an overall safety score of 85 out of 100. Patients taking PEGINTERFERON ALFA 2A who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
PYREXIA3,471 of 141,362 reports
PYREXIA is a less commonly reported adverse event for PEGINTERFERON ALFA 2A, but still significant enough to appear in the safety profile.
Other Side Effects of PEGINTERFERON ALFA 2A
In addition to pyrexia, the following adverse reactions have been reported for PEGINTERFERON ALFA 2A:
PYREXIA has been reported as an adverse event in 3,471 FDA reports for PEGINTERFERON ALFA 2A. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is PYREXIA with PEGINTERFERON ALFA 2A?
PYREXIA accounts for approximately 2.5% of all adverse event reports for PEGINTERFERON ALFA 2A, making it a notable side effect.
What should I do if I experience PYREXIA while taking PEGINTERFERON ALFA 2A?
If you experience pyrexia while taking PEGINTERFERON ALFA 2A, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.